Magdalena is a writer with a passion for bridging the gap between the people performing research, and those who want or need to understand it. She writes about medical science and drug discovery. She holds an MS in Pharmaceutical Bioscience and a PhD — spanning the fields of psychiatry, immunology, and neuropharmacology — from Karolinska Institutet in Sweden.
Relugolix effectively reduced menstrual bleeding among Japanese women with uterine fibroids, according to results from a Phase 3 trial of the compound, which is also being developed for endometriosis. ... Read more
An endometriosis patient advocate has written a petition urging the American Congress of Obstetricians and Gynecologists (ACOG) to update treatment standards for endometriosis — an area which the petition argues ... Read more
Japanese researchers have found that given dienogest — a synthetic progestogen hormone — to women who have had keyhole surgery for deep infiltrating endometriosis lowers the recurrence rates of both pain ... Read more
Myovant Sciences has started a Phase 3 clinical trial program to see if its therapy relugolix can reduce endometriosis-associated pain. It plans two trials that investigate the safety and effectiveness of relugolix, ... Read more
Assisted reproduction techniques such as in vitro fertilization pose severe risk of placenta previa for women with endometriosis, a new review by a group of Italian researchers warns. Placenta previa occurs ... Read more
Tall, thin girls, adolescents and young women are at higher risk of developing endometriosis, according to a study by U.S. and French researchers. How body composition influences the risk ... Read more
Researchers have identified a new mechanism that likely mediates pain in endometriosis through microRNAs, which in turn affect gene activity of inflammatory and pain-related genes. These microRNAs, researchers argued, can ... Read more